Regeneron Pharmaceuticals (REGN)

Depreciation & Amortization

$123.70M

Quarterly · Period ending: · USD

REGN logo

REGN Depreciation & Amortization

Latest reported$123.70M
REGN Quarterly Depreciation & Amortization ($200.00K → $123.70M)
High-resolution chart · PNG

REGN depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
1,419,000
1,329,000
1,296,000
1,154,000
1,045,000
926,000
900,000
900,000
900,000
700,000
700,000
700,000
700,000
900,000
1,100,000
900,000
1,200,000
1,200,000
1,600,000
1,500,000
1,500,000
1,500,000
1,300,000
1,600,000
1,400,000
1,600,000
1,200,000
1,100,000
1,000,000
900,000
900,000
800,000
700,000
700,000
600,000
500,000
500,000
400,000
300,000
200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.